Ashley Gallagher, Associate Editor from Pharmacy Times - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment		Study: Dark Chocolate Consumption Lowers Risk of Type 2 Diabetes - 8 days ago Tirzepatide Demonstrates Superiority for Weight Loss Compared With Semaglutide - 8 days ago Pneumococcal Infection Reveals Underlying Immunosuppressive Conditions for Low-Risk Adults - 17 days ago Monitoring Serum Magnesium Levels Helps Manage Hypomagnesemia for Patients With Type 2 Diabetes - 18 days ago Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator - 18 days ago Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients - 18 days ago FDA Approves Ustekinumab-kfce as Biosimilar to Ustekinumab - 18 days ago FDA Approves Landiolol For Treatment of Supraventricular Tachycardia - 23 days ago Financial Incentives Increase Utilization of Biosimilars for Oncology Care - 24 days ago Study Shows Adult HPV Vaccination Is Less Cost-Effective Than Adolescent Vaccination - 24 days ago Disappearance of B/Yamagata Strain Influences Flu Vaccine, Public Health Decisions - 25 days ago Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - 28 days ago Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events - 29 days ago Higher Composite Dietary Antioxidant Index Reduces Risk of Diabetes for Women - 29 days ago Investigators Present New Data About HPV Vaccine, Supporting Its Use - about 1 month ago FDA Grants Breakthrough Therapy Designation for Nipocalimab to Treat Sjögren Disease - about 1 month ago Spread of Seasonal Flu Returns to Pre-Pandemic Levels After End of COVID-19 Global Emergency - about 1 month ago FDA Grants Rare Pediatric Disease Designation for Treatment of Neonatal SP-B Deficiency - about 1 month ago Pharmacists Play Key Role in Flu Vaccination Efforts - about 2 months ago Pegfilgrastim-Fpgk Shows Structural, Functional Biosimilarity to Reference Product - about 2 months ago Results of ELEVATUM Show Improvement in Diabetic Macular Edema With Vabysmo for Racial, Ethnic Minority Patients - about 2 months ago Report: 82.3% of Reported Vaccine Errors Reached the Patient - about 2 months ago Survey: 50% of Active Drug Shortages in the United States Persist for 2 or More Years - about 2 months ago Simultaneous Zoster, Inactive Quadrivalent Influenza Vaccination Shows Acceptable Safety for Older Adults - about 2 months ago FDA Accepts Biologic License Application for Biosimilar Denosumab - about 2 months ago Survey: 8 in 10 Patients Believe Immunization Protects Them From Public Health Threats - about 2 months ago Vaccination Rates Increase With Electronic Letter Reminder for Influenza Immunization - about 2 months ago Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - about 2 months ago FDA Approves Oral Sulopenem Etzadroxil and Probenecid for Uncomplicated Urinary Tract Infections - about 2 months ago Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide - about 2 months ago ACIP Lowers Pneumococcal Vaccination Recommendation to Age 50 - about 2 months ago FDA Adds Intravenous Fluids to List of Drug Shortages - 2 months ago FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease - 3 months ago FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis - 3 months ago Remote Interventions From Pharmacists Shown to Improve Blood Glucose Control for Type 2 Diabetes - 3 months ago Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 3 months ago FDA Authorizes OTC Hearing Aid Software Compatible With Apple AirPods - 3 months ago Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 3 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 3 months ago Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 3 months ago Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 3 months ago FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 3 months ago FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 3 months ago Biosimilar of Xolair shows Similarity in Reducing Asthma Exacerbations - 4 months ago Digital Therapeutics in Diabetes Show Potential for Improved Disease Management - 4 months ago FDA Grants Orphan Drug Designation to RAG-18 for Duchenne, Becker Muscular Dystrophy - 4 months ago SELECT Trial Shows Similar Cardiac Benefits of Semaglutide for Heart Failure - 4 months ago Condition Watch, August 2024: Dermatology - 4 months ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 4 months ago Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis - 4 months ago